ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,280Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 12

$1.68M Total Retail Price of All Prescriptions

Rank: 1 out of 12

911 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 911 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

27% of this provider’s 911 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 28,513 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
OMEPRAZOLE 1,166 1,083 1 6
HYDROCODONE-ACETAMINOPHEN 1,154 1,096 S3 2 5
FUROSEMIDE 1,146 1,122 3 2
SIMVASTATIN 1,030 1,012 4 3
LEVOTHYROXINE SODIUM 1,013 988 5 4
LISINOPRIL 1,001 999 6 1
DONEPEZIL HCL 678 662 7 9
NAMENDA 533 520 8 11
CITALOPRAM HBR 530 518 9 15
GABAPENTIN 476 442 10 14
WARFARIN SODIUM 469 437 11 8
ATENOLOL 457 436 12 22
POLYETHYLENE GLYCOL 3350 454 422 13 19
METOPROLOL SUCCINATE 415 411 14 21
AMLODIPINE BESYLATE 412 401 15 7
ESCITALOPRAM OXALATE 355 347 16 25
POTASSIUM CHLORIDE 346 316 17 13
LANTUS 331 308 18 23
NYSTATIN 329 293 19 47
METFORMIN HCL 325 322 20 12
SERTRALINE HCL 321 299 21 17
SULFAMETHOXAZOLE-TRIMETHOPRIM 289 261 22 39
MIRTAZAPINE 285 242 23 24
LOSARTAN POTASSIUM 282 281 24 38
CARBIDOPA-LEVODOPA 262 255 25 49
METOPROLOL TARTRATE 260 253 26 10
ZOLPIDEM TARTRATE 250 243 27 29
HYDROCHLOROTHIAZIDE 239 235 28 16
FENTANYL 232 199 S2 29 32
ATORVASTATIN CALCIUM 219 211 30 18
DIOVAN 210 209 31 69
CLOPIDOGREL 199 199 32 33
CYMBALTA 196 153 33 33
NOVOLOG 193 193 34 50
CARVEDILOL 178 177 35 26
TAMSULOSIN HCL 176 176 36 27
ALENDRONATE SODIUM 173 173 37 35
RISPERIDONE 171 169 38 28
OXYCODONE-ACETAMINOPHEN 167 160 S2 39 58
ALLOPURINOL 164 164 40 52
FAMOTIDINE 160 146 41 46
ROPINIROLE HCL 160 160 41 78
LEVOFLOXACIN 156 146 43 87
DIVALPROEX SODIUM 154 142 44 30
PREDNISONE 152 151 45 51
LEVETIRACETAM 151 120 46 77
SPIRONOLACTONE 146 138 47 57
PLAVIX 145 145 48 56
PANTOPRAZOLE SODIUM 143 124 49 31
OXYBUTYNIN CHLORIDE 138 117 50 89
FLUTICASONE PROPIONATE 132 116 51 41
ALBUTEROL SULFATE 132 123 51 75
QUETIAPINE FUMARATE 127 117 53 40
DIGOXIN 125 123 54 42
KLOR-CON 10 124 123 55 102
PROMETHAZINE HCL 123 106 R 56 67
ISOSORBIDE MONONITRATE ER 123 122 56 60
LIDOCAINE HCL 121 115 58 105
TRAMADOL HCL 121 117 58 20
PAROXETINE HCL 121 121 58 55
LOSARTAN-HYDROCHLOROTHIAZIDE 120 120 61 106
AZITHROMYCIN 115 111 62 48
SYNTHROID 115 115 62 109
ONDANSETRON HCL 115 103 62 109
LIDODERM 113 113 65 83
CLONIDINE HCL 113 102 65 72
ADVAIR DISKUS 111 106 67 43
SPIRIVA 111 105 67 76
VENLAFAXINE HCL ER 108 108 69 63
ULORIC 102 102 70 111
LYRICA 99 88 71 70
JANTOVEN 98 98 72 113
VESICARE 98 98 72 113
DILTIAZEM 24HR CD 95 94 74 117
PRAVASTATIN SODIUM 95 95 74 36
CEPHALEXIN 93 85 76 53
HUMALOG 93 76 76 95
NYSTOP 93 57 76 118
OLANZAPINE 93 84 76 66
PHENYTOIN SODIUM EXTENDED 91 69 80 91
CRESTOR 86 84 81 81
RANITIDINE HCL 86 84 81 44
LIDOCAINE 84 67 83 122
HYDROXYZINE HCL 80 72 R 84 125
MORPHINE SULFATE ER 80 56 S2 84 125
JANUVIA 79 72 86 88
FINASTERIDE 79 79 86 127
LEXAPRO 79 79 86 94
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 77 89 85
BENICAR 76 76 90 130
MELOXICAM 76 76 90 59
TRAZODONE HCL 76 76 90 37
LOVASTATIN 76 75 90 130
TRIAMTERENE-HCTZ 75 75 94 74
KLOR-CON M20 73 73 95 54
CIPROFLOXACIN HCL 72 69 96 86
GLIPIZIDE ER 71 71 97 136
NITROFURANTOIN 71 70 97 136
MORPHINE SULFATE 69 65 S2 99 138
FENOFIBRATE 69 50 99 138
SINGULAIR 69 58 99 104
BACLOFEN 66 23 102 90
CELEBREX 66 66 102 98
HYDROCORTISONE 66 58 102 146
KETOCONAZOLE 63 59 105 149
FLUOXETINE HCL 62 53 106 62
DILTIAZEM 24HR ER 62 62 106 150
GLIPIZIDE 61 45 108 71
NITROSTAT 61 60 108 151
CEFDINIR 60 58 110 153
QUINAPRIL HCL 59 59 111 156
AMLODIPINE BESYLATE-BENAZEPRIL 57 56 112 157
BUSPIRONE HCL 56 48 113 92
ENALAPRIL MALEATE 55 55 114 73
VENLAFAXINE HCL 55 52 114 160
TRIAMCINOLONE ACETONIDE 55 54 114 160
VOLTAREN 55 55 114 160
SEROQUEL 54 54 118 84
RIVASTIGMINE 53 53 119 165
BENAZEPRIL HCL 53 44 119 107
NEXIUM 52 52 121 45
NITROFURANTOIN MONO-MACRO 52 46 121 102
PROPRANOLOL HCL 51 51 123 169
ABILIFY 51 44 123 79
SUCRALFATE 50 45 125 170
METOCLOPRAMIDE HCL 50 32 125 170
PROAIR HFA 50 37 125 64
ACETIC ACID 50 49 125 170
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.